Alberta Health Services. (2013, October). Muscle Invasive and Locally Advanced/Metastatic Bladder Cancer Clinical Practice Guideline GU-002 (Version 5). Retrieved from: https://www.albertahealthservices.ca/assets/info/hp/cancer/if-hp-cancer-guide-gu002-bladder.pdf.
American Cancer Society. (2016, January 26). Treating Bladder Cancer. Retrieved from: https://www.cancer.org/cancer/bladder-cancer/treating.html.
American Society of Clinical Oncology. (2017, October). Bladder Cancer. Retrieved from: https://www.cancer.net/cancer-types/bladder-cancer.
Cancer Care Ontario. (2017). Bladder Cancer Diagnosis, Treatment and Follow-up Care Pathway Map (Version 2017.02). Retrieved from: http://ocp.cancercare.on.ca/cms/One.aspx?portalId=327895&pageId=370578.
Drugs and Health Products, Health Canada. (2017, September 9). Regulatory Decision Summary: Keytruda. Retrieved from: https://hpr-rps.hres.ca/reg-content/regulatory-decision-summary-detail.php?lang=en&linkID=RDS00286.
Drugs and Health Products, Health Canada. (2018, February 21). Summary Basis of Decision (SBD) for IMFINZI. Retrieved from: https://hpr-rps.hres.ca/reg-content/summary-basis-decision-detailTwo.php?linkID=SBD00384.
Feldman AS, Efstathiou JA, Lee RJ, Dahl DM, Michaelson MD, Zietman AL. Cancer of the bladder, ureter, and renal pelvis. DeVita VT Jr, Lawrence TS, Rosenberg SA. (2015). Cancer: Principles and Practice of Oncology. (10th Edition). Philadelphia: Wolters Kluwer Health/Lippincott Williams & Wilkins. 65:896-916.
National Cancer Institute. (2018, April 12). Bladder Cancer Treatment (PDQ®) Health Professional Version. Retrieved from: https://www.cancer.gov/types/bladder/hp/bladder-treatment-pdq.
National Comprehensive Cancer Network. NCCN Clinical Practice Guidelines in Oncology: Bladder Cancer (Version 5.2018).
Penn Medicine. (2017, October 12). All About Bladder Cancer. University of Pennsylvania. Retrieved from: https://www.oncolink.org/cancers/urinary-tract/bladder-cancer/all-about-bladder-cancer.×